Chemotherapy-Induced Changes in Body Composition among Breast Cancer Patients: A Scoping Review

• T. Akshaya

  Sri Ramachandra Faculty of Physiotherapy, Sri Ramachandra Institute of Higher Education and Research (DU), India

• T. Senthil Kumar

  Sri Ramachandra Faculty of Physiotherapy, Sri Ramachandra Institute of Higher Education and Research (DU), India

• R. Yogeshwari

  Sri Ramachandra Faculty of Physiotherapy, Sri Ramachandra Institute of Higher Education and Research (DU), India

• S. Sridevi

  Sri Ramachandra Faculty of Physiotherapy, Sri Ramachandra Institute of Higher Education and Research (DU), India

• N. Venkatesh

  Sri Ramachandra Faculty of Physiotherapy, Sri Ramachandra Institute of Higher Education and Research (DU), India

The fundamental use of chemotherapy in breast cancer treatment leads to substantial body composition alterations which cause sarcopenia combined with fat deposition as well as body weight irregularities. Following chemotherapy, there are changes that impact the patient's tolerance as well as their overall health and prognosis. Such changes in body composition require precise understanding for the improvement of patient care and effective treatment development. This study used following databases, including PubMed, OVID and PEDro and the eligibility and screening process led to the selection of nine studies in the review. Nine studies examined weight and body composition changes during chemotherapy in breast cancer patients, revealed significant increases in body weight and fat mass. Notably, gaining weight while undergoing chemotherapy was linked to worse survival outcomes, such as a decline in overall survival (OS) and disease-free survival (DFS). Furthermore, sarcopenia has a detrimental effect on the results of chemotherapy, increasing toxicity and decreasing response to treatment. Comparative studies indicated that breast cancer patients experienced increase fat mass and decreased lean body mass during chemotherapy compared to controls without cancer, with these changes persisting after treatment. Patients receiving chemotherapy developed changes in their body composition that result in sarcopenia and fat mass gain. The alterations cause lower chemotherapy effectiveness and elevated chemotherapy toxicity levels. Understanding these changes is essential for patient assessment, therapeutic development and complication prevention.

[1] Sathishkumar K, Sankarapillai J, Mathew A, Nair RA, Gangane N, Khuraijam S, Barmon D, Pandya S, Majumdar G, Deshmane V, et al. Breast Cancer Survival in India Across 11 Geographic Areas Under the National Cancer Registry Programme. Cancer 2024; 130(10): 1816-1825.

[2] Wood N, Morton M, Shah SN, Yao M, Barnard H, Tewari S, Suresh A, Kollikonda S, AlHilli MM. Association Between CT-Based Body Composition Assessment and Patient Outcomes During Neoadjuvant Chemotherapy for Epithelial Ovarian Cancer. Gynecol Oncol 2023; 169(1): 55-63.

[3] Vance V, Mourtzakis M, Hanning R. Relationships Between Weight Change and Physical and Psychological Distress in Early-Stage Breast Cancer Survivors. Cancer Nursing 2019; 42(3): E43-E50.

[4] Alacacioglu A, et al. Leptin, Insulin, and Body Composition Changes during Adjuvant Taxane- Based Chemotherapy in Patients with Breast Cancer: Preliminary Study. Indian Journal of Cancer 2016; 53(1): 39-42.

[5] Fang Q, et al. Percent Body Fat Change in Chinese Women after Adjuvant Chemotherapy for Breast Cancer. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2018; 24: 5988.

[6] Pedersen B, et al. Changes in Weight and Body Composition Among Women with Breast Cancer During and After Adjuvant Treatment: A Prospective Follow-Up Study. Cancer Nursing 2017; 40(5): 369-376.

[7] Schvartsman G, et al. Association Between Weight Gain During Adjuvant Chemotherapy for Early-Stage Breast Cancer and Survival Outcomes. Cancer Medicine 2017; 6(11): 2515-2522.

[8] Di Leone A, et al. The Role of Body Composition in Neurological and Hematologic Toxicity in a Retrospective Analysis of 120 Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: The COMBOTOX Study. Breast Cancer Research and Treatment 2025; 210(1): 205-213.

[9] Van den Berg MMGA, et al. Changes in Body Composition During and After Adjuvant or Neo-Adjuvant Chemotherapy in Women with Breast Cancer Stage I-IIIB Compared with Changes Over a Similar Timeframe in Women Without Cancer. Supportive Care in Cancer 2020; 28: 1685-1693.

[10] DeKruif JThCM, et al. A Longitudinal Mixed Methods Study on Changes in Body Weight, Body Composition, and Lifestyle in Breast Cancer Patients during Chemotherapy and in a Comparison Group of Women without Cancer: Study Protocol. BMC Cancer 2019; 19: 1-8.

[11] Karaca M, et al. Sarcopenia’s Role in Neoadjuvant Chemotherapy Outcomes for Locally Advanced Breast Cancer: A Retrospective Analysis. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2024; 30: e945240.

[12] Godinho-Mota JCM, Mota JF, Gonçalves LV, Soares LR, Schincaglia RM, Prado CM, Martins KA, Freitas-Junior R. Chemotherapy Negatively Impacts Body Composition, Physical Function and Metabolic Profile in Patients with Breast Cancer. Clin Nutr 2020; 40(1): 108-115.

• PDF

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.